首页> 美国卫生研究院文献>Journal of Surgical Case Reports >Sunitinib cause delayed complete response on metastatic RCC and extensive IVC thrombus but not to the kidney tumor: a case report and review of literature
【2h】

Sunitinib cause delayed complete response on metastatic RCC and extensive IVC thrombus but not to the kidney tumor: a case report and review of literature

机译:舒尼替尼可导致转移性RCC和广泛的IVC血栓延迟完全反应但未引起肾脏肿瘤:一例病例报告和文献复习

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The role of cytoreductive nephrectomy for metastatic renal cell carcinoma (RCC) is currently debated, with the advancements in target therapy development. The aim of our work was to present an interesting case report with mini review to describe the important role of cytoreductive nephrectomy for kidney cancer control that failed to respond well to Sutent, in spite of good response for all metastases. Medline review of related English publication was conducted and included to the study. RCC response to Sutent is inferior to the response of its metastases. Cytoreductive nephrectomy still plays an important role in metastatic RCC and may be an integral part for cancer control, in properly selected patients.
机译:随着靶标治疗方法的发展,细胞减少性肾切除术在转移性肾细胞癌(RCC)中的作用目前受到争议。我们的工作目的是提供一个有趣的病例报告,并进行简短回顾,以描述尽管所有转移均反应良好,但细胞减少性肾切除术对未能成功对Sutent做出良好反应的肾癌控制的重要作用。对相关英文出版物进行Medline审查,并将其纳入研究。 RCC对Sutent的反应不如其转移反应。在适当选择的患者中,细胞减少性肾切除术仍在转移性RCC中起着重要作用,并且可能是控制癌症的重要组成部分。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号